Tag: Julius Few

All

In April's Behind the Scenes, practice manager Shay Moinuddin discusses how she helped the Few Institute go paperless.

Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.